These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29338289)

  • 1. A systematic review of risk factors for methamphetamine-associated psychosis.
    Arunogiri S; Foulds JA; McKetin R; Lubman DI
    Aust N Z J Psychiatry; 2018 Jun; 52(6):514-529. PubMed ID: 29338289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S
    Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
    [No Abstract]   [Full Text] [Related]  

  • 3. The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia.
    Sulaiman AH; Said MA; Habil MH; Rashid R; Siddiq A; Guan NC; Midin M; Nik Jaafar NR; Sidi H; Das S
    Compr Psychiatry; 2014 Jan; 55 Suppl 1():S89-94. PubMed ID: 23433219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.
    Grelotti DJ; Kanayama G; Pope HG
    Am J Psychiatry; 2010 Jan; 167(1):17-23. PubMed ID: 20068123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive and negative symptoms in methamphetamine-induced psychosis compared to schizophrenia: A systematic review and meta-analysis.
    Cohen-Laroque J; Grangier I; Perez N; Kirschner M; Kaiser S; Sabé M
    Schizophr Res; 2024 May; 267():182-190. PubMed ID: 38554698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
    Yang M; Yang C; Liu T; London ED
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):31-37. PubMed ID: 31609149
    [No Abstract]   [Full Text] [Related]  

  • 8. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amphetamine-induced psychosis or schizophrenia?].
    Rognli EB; Medhus SE; Bramness JG
    Tidsskr Nor Laegeforen; 2015 Feb; 135(3):249-51. PubMed ID: 25668544
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychosis induced by amphetamines.
    Bramness JG; Rognli EB
    Curr Opin Psychiatry; 2016 Jul; 29(4):236-41. PubMed ID: 27175554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine psychosis: epidemiology and management.
    Glasner-Edwards S; Mooney LJ
    CNS Drugs; 2014 Dec; 28(12):1115-26. PubMed ID: 25373627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence.
    Willi TS; Honer WG; Thornton AE; Gicas K; Procyshyn RM; Vila-Rodriguez F; Panenka WJ; Aleksic A; Leonova O; Jones AA; MacEwan GW; Barr AM
    Psychiatry Res; 2016 Jun; 240():336-342. PubMed ID: 27138828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
    Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
    J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter to the Editor-Is Chronic Methamphetamine-Induced Psychosis A Mental Disease for the Purposes of Insanity?
    Reisner AD; Piel JL
    J Forensic Sci; 2020 Jul; 65(4):1382-1383. PubMed ID: 32396213
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.
    Salo R; Fassbender C; Iosif AM; Ursu S; Leamon MH; Carter C
    Psychiatry Res; 2013 Dec; 210(2):529-35. PubMed ID: 23896355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a discrete negative symptom syndrome in people who use methamphetamine?
    Voce A; Burns R; Castle D; Calabria B; McKetin R
    Compr Psychiatry; 2019 Aug; 93():27-32. PubMed ID: 31301605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine use and psychotic symptoms: findings from a New Zealand longitudinal birth cohort.
    Boden JM; Foulds JA; Newton-Howes G; McKetin R
    Psychol Med; 2023 Feb; 53(3):987-994. PubMed ID: 34134802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower folate levels in methamphetamine-induced psychosis: A cross-sectional study.
    Hadizadeh H; Salehi M; Bozorgnia AR; Ahmadkhaniha HR
    Drug Alcohol Depend; 2020 Feb; 207():107682. PubMed ID: 31841749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.